Massive Conglomerate Gobbles Up Tylenol Maker In $48.7 Billion Mega-Deal

0
108

Kimberly-Clark announced Monday that it will buy Kenvue for around $48.7 billion, uniting the Huggies diaper maker with the company behind Tylenol and Band-Aid.

Under the agreement, Kenvue investors get a mix of $3.50 cash and stock worth $21.01 total per share using Kimberly-Clark’s stock price from the end of October, according to a press release from Kimberly-Clark Corporation and Kenvue Inc. Those currently holding Kimberly-Clark shares will own about 54 percent of the merged business with Kenvue shareholders holding the rest.

“We are excited to bring together two iconic companies to create a global health and wellness leader,” Kimberly-Clark Chairman and Chief Executive Officer Mike Hsu said. “Kenvue is uniquely positioned at the intersection of CPG and healthcare, with exceptional talent and a differentiated brand offering serving attractive consumer health…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here